![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | SLMAP (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLMAP mRNA | CTD | PMID:22079256 | 1,2-dimethylhydrazine | increases expression | ISO | Slmap (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of SLMAP mRNA | CTD | PMID:22206623 | 1-nitropyrene | increases expression | ISO | SLMAP (Homo sapiens) | 6480464 | 1-nitropyrene results in increased expression of SLMAP mRNA | CTD | PMID:19041380 | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of SLMAP mRNA | CTD | PMID:32145629 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Slmap (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of SLMAP mRNA | CTD | PMID:21570461 more ... | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of SLMAP mRNA | CTD | PMID:33387578 | 4-hydroxyphenyl retinamide | increases expression | ISO | Slmap (Mus musculus) | 6480464 | Fenretinide results in increased expression of SLMAP mRNA | CTD | PMID:28973697 | 4-vinylcyclohexene dioxide | affects expression | ISO | Slmap (Mus musculus) | 6480464 | 4-vinyl-1-cyclohexene dioxide affects the expression of SLMAP mRNA | CTD | PMID:20829426 | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of SLMAP mRNA | CTD | PMID:30047161 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of SLMAP mRNA | CTD | PMID:28959563 | aflatoxin B1 | increases expression | ISO | Slmap (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of SLMAP mRNA | CTD | PMID:19770486 | aflatoxin B1 | increases methylation | ISO | SLMAP (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of SLMAP intron | CTD | PMID:30157460 | antirheumatic drug | increases expression | ISO | SLMAP (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of SLMAP mRNA | CTD | PMID:24449571 | Aroclor 1254 | decreases expression | ISO | Slmap (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of SLMAP mRNA | CTD | PMID:23650126 | arsane | affects methylation | ISO | SLMAP (Homo sapiens) | 6480464 | Arsenic affects the methylation of SLMAP gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | SLMAP (Homo sapiens) | 6480464 | Arsenic affects the methylation of SLMAP gene | CTD | PMID:25304211 | atrazine | increases expression | ISO | SLMAP (Homo sapiens) | 6480464 | Atrazine results in increased expression of SLMAP mRNA | CTD | PMID:22378314 | benzo[a]pyrene | increases expression | ISO | Slmap (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of SLMAP mRNA | CTD | PMID:22228805 | benzo[a]pyrene | affects methylation | ISO | SLMAP (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of SLMAP intron | CTD | PMID:30157460 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | SLMAP (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SLMAP mRNA | CTD | PMID:25181051 | bisphenol A | decreases methylation | ISO | SLMAP (Homo sapiens) | 6480464 | bisphenol A results in decreased methylation of SLMAP gene | CTD | PMID:31601247 | bisphenol A | decreases expression | ISO | Slmap (Mus musculus) | 6480464 | bisphenol A results in decreased expression of SLMAP mRNA | CTD | PMID:33221593 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of SLMAP mRNA | CTD | PMID:32145629 | C60 fullerene | decreases expression | EXP | | 6480464 | fullerene C60 results in decreased expression of SLMAP mRNA | CTD | PMID:19167457 | caffeine | affects phosphorylation | ISO | SLMAP (Homo sapiens) | 6480464 | Caffeine affects the phosphorylation of SLMAP protein | CTD | PMID:35688186 | chrysene | increases expression | ISO | Slmap (Mus musculus) | 6480464 | chrysene results in increased expression of SLMAP mRNA | CTD | PMID:26377693 | cisplatin | decreases expression | ISO | SLMAP (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of SLMAP mRNA | CTD | PMID:27594783 | copper(II) sulfate | increases expression | ISO | SLMAP (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of SLMAP mRNA | CTD | PMID:19549813 | crocidolite asbestos | decreases expression | ISO | Slmap (Mus musculus) | 6480464 | Asbestos and Crocidolite results in decreased expression of SLMAP mRNA | CTD | PMID:29279043 | cyclosporin A | increases expression | ISO | SLMAP (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of SLMAP mRNA | CTD | PMID:20106945 | dibutyl phthalate | increases expression | ISO | Slmap (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of SLMAP mRNA | CTD | PMID:17361019 and PMID:21266533 | doxorubicin | increases oxidation | EXP | | 6480464 | Doxorubicin results in increased oxidation of SLMAP protein | CTD | PMID:28818578 | doxorubicin | decreases expression | ISO | SLMAP (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of SLMAP mRNA | CTD | PMID:29803840 | enzyme inhibitor | multiple interactions | ISO | SLMAP (Homo sapiens) | 6480464 | [Enzyme Inhibitors results in decreased activity of OGA protein] which results in increased O-linked glycosylation of SLMAP protein | CTD | PMID:23301498 | ethyl methanesulfonate | decreases expression | ISO | SLMAP (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in decreased expression of SLMAP mRNA | CTD | PMID:23649840 | formaldehyde | decreases expression | ISO | SLMAP (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of SLMAP mRNA | CTD | PMID:23649840 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of SLMAP mRNA | CTD | PMID:33387578 | hyaluronic acid | decreases expression | EXP | | 6480464 | Hyaluronic Acid analog results in decreased expression of SLMAP protein | CTD | PMID:23178681 | hydrogen peroxide | multiple interactions | ISO | SLMAP (Homo sapiens) | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of SLMAP protein | CTD | PMID:18951874 | hydrogen peroxide | decreases expression | EXP | | 6480464 | Hydrogen Peroxide results in decreased expression of SLMAP protein | CTD | PMID:23178681 | hypochlorous acid | increases expression | ISO | Slmap (Mus musculus) | 6480464 | Hypochlorous Acid results in increased expression of SLMAP mRNA | CTD | PMID:19376150 | menadione | affects expression | ISO | Slmap (Mus musculus) | 6480464 | Vitamin K 3 affects the expression of SLMAP mRNA | CTD | PMID:20829426 | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of SLMAP mRNA | CTD | PMID:30047161 | methoxychlor | affects expression | ISO | Slmap (Mus musculus) | 6480464 | Methoxychlor affects the expression of SLMAP mRNA | CTD | PMID:20829426 | perfluorooctanoic acid | decreases expression | ISO | SLMAP (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of SLMAP protein | CTD | PMID:26879310 | pirinixic acid | multiple interactions | ISO | SLMAP (Homo sapiens) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLMAP mRNA | CTD | PMID:19710929 | potassium chromate | multiple interactions | ISO | SLMAP (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLMAP mRNA | CTD | PMID:22079256 | potassium chromate | decreases expression | ISO | SLMAP (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of SLMAP mRNA | CTD | PMID:22079256 | resveratrol | multiple interactions | ISO | SLMAP (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of SLMAP mRNA | CTD | PMID:23557933 | sodium fluoride | increases expression | ISO | Slmap (Mus musculus) | 6480464 | Sodium Fluoride results in increased expression of SLMAP mRNA | CTD | PMID:27862939 | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of SLMAP mRNA | CTD | PMID:30047161 | sunitinib | decreases expression | ISO | SLMAP (Homo sapiens) | 6480464 | Sunitinib results in decreased expression of SLMAP mRNA | CTD | PMID:31533062 | tetrachloroethene | increases expression | ISO | Slmap (Mus musculus) | 6480464 | Tetrachloroethylene results in increased expression of SLMAP mRNA | CTD | PMID:28973375 | theophylline | multiple interactions | ISO | SLMAP (Homo sapiens) | 6480464 | [Hydrogen Peroxide co-treated with Theophylline] results in increased expression of SLMAP protein | CTD | PMID:18951874 | titanium dioxide | increases expression | ISO | Slmap (Mus musculus) | 6480464 | titanium dioxide results in increased expression of SLMAP mRNA | CTD | PMID:23557971 | toxaphene | decreases expression | EXP | | 6480464 | Toxaphene results in decreased expression of SLMAP mRNA | CTD | PMID:23153324 | triptonide | decreases expression | ISO | Slmap (Mus musculus) | 6480464 | triptonide results in decreased expression of SLMAP mRNA | CTD | PMID:33045310 | tungsten | decreases expression | ISO | Slmap (Mus musculus) | 6480464 | Tungsten results in decreased expression of SLMAP mRNA | CTD | PMID:30912803 | valproic acid | increases expression | ISO | SLMAP (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SLMAP mRNA | CTD | PMID:23179753 | zoledronic acid | increases expression | ISO | SLMAP (Homo sapiens) | 6480464 | zoledronic acid results in increased expression of SLMAP mRNA | CTD | PMID:20977926 | |